Sign In
Buy HCM
$9.99
-0.290 (-2.82%)
At Close: Jun 22, 2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enr
Best Momentum Stock to Buy for August 19th
11:00am, Tuesday, 19'th Aug 2025
CENX, MC and HCM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 19, 2025.
HUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call Transcript
03:59am, Friday, 08'th Aug 2025
HUTCHMED (China) Limited (NASDAQ:HCM ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Chig Fung Cheng - CFO & Executive Director David Ng - Head of Investor Relations
HCM III Acquisition Corp Announces Closing of $253,000,000 Initial Public Offering
07:16pm, Monday, 04'th Aug 2025
STAMFORD, Ct, Aug. 04, 2025 (GLOBE NEWSWIRE) -- HCM III Acquisition Corp (Nasdaq: HCMAU) (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share ex
HCM III Acquisition Corp. Announces Pricing of $220 Million Initial Public Offering
08:37pm, Thursday, 31'st Jul 2025
STAMFORD, CT, July 31, 2025 (GLOBE NEWSWIRE) -- HCM III Acquisition Corp. (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset a
HUTCHMED to Announce 2025 Half-Year Financial Results
04:30am, Thursday, 03'rd Jul 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six mont
— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —
How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%
10:56am, Monday, 23'rd Jun 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 73.5% in HUTCHMED (HCM). While the effectiveness of this highly sought-after metric is questionable, the positi
Paycom Software: Automating Payroll And HCM Solutions; Initiate With 'Buy'
05:32am, Sunday, 22'nd Jun 2025
I am initiating Paycom with a 'buy' rating and a $280 fair value, driven by strong automation-focused HCM solutions. Paycom's innovations like Beti and GONE automate payroll and time-off processes, su
Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
11:02am, Thursday, 05'th Jun 2025
The mean of analysts' price targets for HUTCHMED (HCM) points to a 68.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerciali
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) and Innovent Biologics, Inc. (“Innovent”)
HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
08:00pm, Sunday, 01'st Jun 2025
— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study —
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
08:00pm, Thursday, 22'nd May 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several stu
Fragmented HCM systems jeopardize business efficiency, Paycom research reveals
04:05pm, Monday, 19'th May 2025
OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud-based human capital management software, discovered surveyed businesses re
